BDBM50335207 CHEMBL1650731::N4-[5-(dimethylamino)-1H-pyrazol-3-yl]-5-fluoro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]pyrimidine-2,4-diamine

SMILES C[C@H](Nc1ncc(F)c(Nc2cc(n[nH]2)N(C)C)n1)c1ncc(F)cn1

InChI Key InChIKey=UGAAPUDPSIDFJZ-QMMMGPOBSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50335207   

TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Astrazeneca R&D

Curated by ChEMBL
LigandPNGBDBM50335207(CHEMBL1650731 | N4-[5-(dimethylamino)-1H-pyrazol-3...)
Affinity DataIC50:  815nMAssay Description:Inhibition of JAK2 using 5 mM of ATPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Astrazeneca R&D

Curated by ChEMBL
LigandPNGBDBM50335207(CHEMBL1650731 | N4-[5-(dimethylamino)-1H-pyrazol-3...)
Affinity DataIC50:  16nMAssay Description:Inhibition of JAK2 using Km ATP concentrationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Astrazeneca R&D

Curated by ChEMBL
LigandPNGBDBM50335207(CHEMBL1650731 | N4-[5-(dimethylamino)-1H-pyrazol-3...)
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of JAK3 using 5 mM of ATPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed